Navigation Links
GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
Date:6/18/2008

- Company To Actively Pursue Acquisition Opportunities -

BRIDGEWATER, N.J. and NEW YORK, June 18 /PRNewswire/ -- GANIC Pharmaceuticals, a new specialty pharmaceutical company, today announced its launch backed by Warburg Pincus, the leading global private equity firm. Warburg Pincus has made an initial investment in GANIC from Warburg Pincus Private Equity X, L.P., a $15 billion fund, which closed in April.

GANIC Pharmaceuticals was founded by a highly seasoned group of senior executives with 65 years of collective experience in the pharmaceutical industry, in partnership with Warburg Pincus. The company's founders include Paul Edick, Chief Executive Officer, Chief Financial Officer Corey Fishman, and Chief Commercial Officer Chris Maltese, all formerly senior executives at MedPointe Pharmaceuticals.

Paul Edick, CEO of GANIC Pharmaceuticals, said, "We see tremendous opportunities for profitable growth and expansion across our targeted areas of focus. We believe that we have the expertise, industry networks, talent base and funding to begin executing towards our objectives. We are very pleased to have as our sole investor, Warburg Pincus, a firm with great insight and expertise in our arena, which shares our strategic vision to build a great company."

GANIC Pharmaceuticals will focus on building a substantial enterprise by acquiring revenue-generating companies, portfolios and/or products and by investing in innovation and acquiring pipeline development assets. GANIC plans to target certain specialty pharmaceutical areas.

Commenting on the investment, Jonathan S. Leff, a Managing Director of Warburg Pincus, stated, "We are delighted to partner with the GANIC team, which has a proven track record for delivering value to investors and the pharmaceutical marketplace. We are confident that their strategy and ability to execute effectively, when combined with our funding and strategic support, will enable them to build a sub
'/>"/>

SOURCE GANIC Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich Signs Agreement With Plextronics to Distribute Plexcore(R) Organic Electronics Materials
2. SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing
3. Directed self-ordering of organic molecules for electronic devices
4. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
5. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
6. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
8. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
9. Celator(R) Pharmaceuticals to Present at 2008 BIO International Convention
10. Scimitar Equity, LLC Initiates Coverage Review of VioQuest Pharmaceuticals, Inc.
11. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... /PRNewswire-Asia/ -- The world is going through,e...ertainty is part of many,businesses and industries...elatively immune to the economic downturn, because...g the midst of the difficult times this year, the ...ated an R&D center in Shanghai, the largest of...
(Date:12/2/2009)... According to the National Institut... diagnosed with diabetes already have some stage o...age to the retina caused by leaky blood vessels, i...es and is one of the most feared diabetic complica...who,ve had diabetes for 10 years or more will expe...
(Date:12/1/2009)...ec. 1 PDL BioPharma, Inc...uidance for the fourth quarter ended December 31, ...h $69 million for the fourth quarter of 2008. Incl...of two installment payments of $12.5 million from ...ults was a one-time $1.8 million payment from Gene...
(Date:12/1/2009)... Reportlinker.com announces that a ...alogue: ,, Industrial Enzymes - A Global Marke...431/Industrial-Enzymes---A-Global-Market-Report.ht...y with few strong players and a host of small supp...petition and commoditization characterize the indu...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...O, SOUTH SAN FRANCISCO, Calif., May 28 Exelixis,...alyst briefing in,conjunction with the 44th Annual...ogy (ASCO) from 6:00 p.m. to 8:00 p.m. CT on Monda...ngos, PhD, President and Chief Executive Officer ...h and Development -- Gisela M. Schwab, MD, Execut...
...website initially focusing on proteins and their r...technology underlying the site has been developed ...escribed in BioMed Centrals open access journal Ge...ommunity annotation on a huge scale. , The artic...l Center in Rotterdam, and the Leiden University M...
...tion, carbon nanotubes which are about 100,000 ti...unique and very useful properties have become the...anosized electronic and mechanical devices. But it...ell as their tendency to clump together, that make...es. , Dr. Ernesto Joselevich, together with Ph.D....
Other Biology Technology:REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 2REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 3REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 4Large-scale community protein annotation -- WikiProteins 2Weizmann Institute scientists create new nanotube structures 2
(Date:12/3/2009)...e measured CO2 levels for the past three years in ... inhabited rural area near Valladolid. The results... Peninsula, show that the levels rose "significant...physicists and meteorologists have been trying to ...w these have evolved in the troposphere over vario...
(Date:12/3/2009)... Antarctic snowmelt that occurred during the 2008-...ong positive phases for two main climate drivers, ...hern Hemisphere Annular Mode), according to Dr. Ma...heric Sciences at The City College of New York. ... faculty at the CUNY Graduate Center, added that A...
(Date:12/2/2009)... results strengthen the evidence that people who s... increased risk for developing colorectal cancer, ..."This provides one more reason not to smoke, or to...hael J. Thun, M.D., M.S., vice president emeritus,...rican Cancer Society. "Colorectal cancer should be...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 1Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 3Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 4Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 5Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 6Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 7Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 8Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 9Professor Nancy Ip Joins aTyr Pharmas Scientific Advisory Board 13585 1Professor Nancy Ip Joins aTyr Pharmas Scientific Advisory Board 13585 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 1BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 3
..., ISRAEL, April 28, 2009 ZenithSolar, an Israeli ...near Tel Aviv on April 26, based on concentrated p... Faiman of Ben-Gurion University of the Negev (BG...rman of the Department of Solar Energy and Environ... for Desert Research, believes the new system will...
...s will gather soon for the 61st Annual Meeting of ...ty of America, being held 11-13 May 2009 in Orem, ... meeting in their new library building on the UVU ... The technical program, presented by academic and ...e students, will highlight cutting-edge scientific...
...ll. Researchers at the University of Illinois hav...the targeted delivery of one or more molecules int... addition to ferrying tiny amounts of cargo, the n...robe and as an optical biosensor., "Nanoneedle-ba...iological processes and biophysical properties at ...
Other Biology News:Ben-Gurion University research and technology used in new solar energy farm 2Geoscientists meet to discuss Rocky Mountain geology 2Nanoneedle is small in size, but huge in applications 2
Mouse Anti-SF3B2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human FBXO11 Monoclonal Antibody, Unconjugated, Clone 4C12 from Abnova Corporation
Mouse Anti-Human LASS3 Polyclonal Antibody, Unconjugated from Abnova Corporation
Rabbit Anti-Nonmuscle Myosin II Heavy Chain B (MHC-B) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc
Biology Products: